Product Information
Enhanced Protease Inhibitor Cocktail is a mix of protease inhibitors with broad specificity for various proteases, composed of Aprotinin, Bestatin, Leupetin, Pepstatin, PMSF, E-64, Phosphoramidon to promote broad spectrum protection against serine, cysteine, and aspartic acid proteases, aminopeptidases, and metalloproteases, and can prevent protein degradation during generation of cell or tissue lysates. The protease inhibitor cocktail can be used in the applications of protein purification, immunoblot, co-immunoprecipitation, immunofluorescence, and immunohistochemistry etc.
A mix of various protease inhibitors, such as Aprotinin, Bestatin, Leupetin, Pepstatin, PMSF, E-64, Phosphoramidon etc.
Storage
Store at -20℃ for a year.
Usage
Desolved at room temperature and briefly vortex the Protease Inhibitor Cocktail (100X) before use, then dilute 1:100 (volume) in cell lysate or lysis buffer.
Cited in Article as
pr20016, Enhanced Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), Proteintech, IL, USA
Documentation
| Datasheet |
|---|
| Enhanced Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) Datasheet |
Publications
| Application | Title |
|---|---|
Immunity Maternal natural killer cells drive neuroimmune disorders in offspring through aberrant secretion of extracellular granzyme B | |
J Extracell Vesicles Dendritic Cell Derived-Extracellular Vesicles Engineered to Express Interleukin-12 and Anti-CTLA-4 on Their Surface for Combinational Cancer Immunotherapy | |
Cell Commun Signal Metformin alleviates bone loss in ovariectomized mice through inhibition of autophagy of osteoclast precursors mediated by E2F1 | |
NPJ Biofilms Microbiomes Impact of structurally diverse polysaccharides on colonic mucin O-glycosylation and gut microbiota | |
Acta Biomater Targeting Delivery of Mifepristone to Endometrial Dysfunctional Macrophages for Endometriosis Therapy | |
Oncogene TIA1 depletion enhances CLSTN1 exon 11 inclusion to facilitate Epithelial-to-Mesenchymal transition and breast cancer metastasis. |